<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01035398</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000450143</org_study_id>
    <secondary_id>MGH-1999-P-010178/23</secondary_id>
    <secondary_id>5R01CA109193-04</secondary_id>
    <nct_id>NCT01035398</nct_id>
  </id_info>
  <brief_title>Genetic and Environmental Risk Factors Related to Esophageal Cancer</brief_title>
  <official_title>Molecular Epidemiology of Esophageal Cancer: Pilot Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Gathering information about genes, cigarette smoking, and diet may help doctors
      learn more about risk factors that may cause esophageal cancer.

      PURPOSE: This clinical trial is studying genetic and environmental risk factors related to
      esophageal cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

        -  Examine the role of several genetically-determined factors in combination with cigarette
           smoking and diet in the etiology and prevention of esophageal cancer.

        -  Identify polymorphisms in metabolizing enzymes (e.g., phase I or II metabolism [GSTM1,
           GSTT1,CYP1A1, CYP3A5, mEH, NQO1, GSTP1], DNA repair [XRCC1, ERCC2], free-radical
           formation [MPO, MnSOD], inflammatory genes [ IL1-beta], metastatic potential [MMP1], and
           cell cycle or tumor suppression [p21, p53]) and related path genes of susceptibility for
           esophageal cancer.

      OUTLINE: Blood and tumor tissue samples are collected. DNA purified from these samples is
      analyzed using DNA-based assays to determine polymorphisms in various related gene pathways.

      Patients complete questionnaires concerning environmental, smoking and diet habits.

      PROJECTED ACCRUAL: A total of 1,000 tissue samples from patients and healthy participants
      (750 patients and 250 healthy participants) will be accrued for this study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2000</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Polymorphisms in various pathways, DNA repair, free-radical formation, inflammatory genes, metastatic potential, and cell cycle or tumor suppression in blood samples</measure>
    <time_frame>2000-2016</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of presence or absence of variant polymorphisms between cases and controls</measure>
    <time_frame>2000-2016</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation between polymorphisms in blood samples and polymorphisms in tissue specimens</measure>
    <time_frame>2000-2016</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Analyses of dietary factors and Helicobacter pylori infection (previous vs current)</measure>
    <time_frame>2000-2016</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Esophageal Cancer</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and/or buccal cells may be collected
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with esophageal cancer and healthy controls aged 45 and over
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Meets 1 of the following criteria:

               -  Diagnosis of esophageal cancer (patient)

                    -  Newly diagnosed disease

                    -  Receiving care at Massachusetts General Hospital, Thoracic Oncology Center

               -  Friend or spouse of patient (healthy participants)

        PATIENT CHARACTERISTICS:

          -  No concurrent psychiatric incapacity or dementia

        PRIOR CONCURRENT THERAPY:

          -  Not specified
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David C. Christiani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Massachusetts General Hospital</last_name>
      <phone>877-726-5130</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Harvard School of Public Health</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David C. Christiani, MD</last_name>
      <phone>617-726-9274</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2009</study_first_submitted>
  <study_first_submitted_qc>December 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2009</study_first_posted>
  <last_update_submitted>August 31, 2017</last_update_submitted>
  <last_update_submitted_qc>August 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>David Christopher Christiani</investigator_full_name>
    <investigator_title>Pulmonary Associate</investigator_title>
  </responsible_party>
  <keyword>stage 0 esophageal cancer</keyword>
  <keyword>stage I esophageal cancer</keyword>
  <keyword>stage II esophageal cancer</keyword>
  <keyword>stage III esophageal cancer</keyword>
  <keyword>stage IV esophageal cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

